NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹21 Cr | ₹15 Cr | ₹21 Cr | ₹14 Cr | ₹6.50 Cr |
What is the latest Short Term Loans and Advances ratio of NGL FINECHEM ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹21 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹21 Cr |
Mar2021 | ₹14 Cr |
Mar2020 | ₹6.50 Cr |
How is Short Term Loans and Advances of NGL FINECHEM Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹21 Cr | 40.13 | |
Mar2023 | ₹15 Cr | -28.97 | |
Mar2022 | ₹21 Cr | 51.58 | |
Mar2021 | ₹14 Cr | 114.79 | |
Mar2020 | ₹6.50 Cr | - |
Compare Short Term Loans and Advances of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,110.0 Cr | -2% | -11% | -8.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -2% |
-11% |
-8.4% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses